Πλοήγηση ανά Συγγραφέα "Hatzimichael, E."

Αποτελέσματα 1-2 από 2

Revisiting bleomycin from pathophysiology to safe clinical use

Froudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E. (2013)

Bleomycin is a key component of curative chemotherapy regimens employed in the treatment of curable cancers, such as Hodgkin lymphoma (HL) and testicular germ-cell tumours (GCT), yet its use may cause bleomycin-induced ...
Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group

Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Kouraklis, A.; Korantzis, I.; Kartasis, Z.; Giannakoulas, N.; Michali, E.; Kokkini, G.; Vagia, M.; Kotsopoulou, M.; Pappa, V.; Papadaki, E.; Bourantas, K.; Matsouka, P.; Anagnostopoulos, N.; Zoumbos, N.; Hellenic, M. D. S. Study Grp (2009)